Original Research

Published on 21 Jan 2022

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Xuhua Duan
Juanfang Liu
Xinwei Han
Jianzhuang Ren
Hao Li
Fengyao Li
Shuguang Ju

Frontiers in Oncology

doi 10.3389/fonc.2021.793581

2,469 views
12 citations

Brief Research Report

Published on 20 Jan 2022

Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia

in Pharmacology of Anti-Cancer Drugs

Mawar Karsa
Emma Ronca
Angelika Bongers
Anna Mariana
Ernest Moles
Timothy W. Failes
Greg M. Arndt
Laurence C. Cheung
Rishi S. Kotecha
Maria Kavallaris

Frontiers in Oncology

doi 10.3389/fonc.2021.779859

3,132 views
3 citations

Case Report

Published on 20 Jan 2022

Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report

in Pharmacology of Anti-Cancer Drugs

Quentin Dominique Thomas
Clémence Basse
Marie Luporsi
Nicolas Girard

Frontiers in Oncology

doi 10.3389/fonc.2021.814544

4,600 views
4 citations

Perspective

Published on 19 Jan 2022

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting System

in Pharmacology of Anti-Cancer Drugs

Hui Yang
Xiaojia Yu
Zhuoling An

Frontiers in Oncology

doi 10.3389/fonc.2021.801199

6,504 views
18 citations

Original Research

Published on 19 Jan 2022

Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study

in Pharmacology of Anti-Cancer Drugs

Ping’an Ding
Peigang Yang
Chenyu Sun
Yuan Tian
Honghai Guo
Yang Liu
Yong Li
Qun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.791912

4,020 views
23 citations

Original Research

Published on 17 Jan 2022

The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis

in Pharmacology of Anti-Cancer Drugs

Haijuan Gu
Yuejiao Zhong
Jibin Liu
Qian Shen
Rong Wei
Haixia Zhu
Xunlei Zhang
Xianxian Xia
Min Yao
Meixin Ni

Frontiers in Oncology

doi 10.3389/fonc.2021.793678

2,986 views
10 citations

Case Report

Published on 13 Jan 2022

Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review

in Pharmacology of Anti-Cancer Drugs

Jianzheng Wang
Hongle Li
Hui Wang
Qingli Li
Xuanye Bai
Huifang Lv
Caiyun Nie
Beibei Chen
Weifeng Xu
Shuiping Tu

Frontiers in Oncology

doi 10.3389/fonc.2021.830672

2,631 views
2 citations

Case Report

Published on 13 Jan 2022

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report

in Pharmacology of Anti-Cancer Drugs

Liting Zhong
Xiaoyu Liu
Zelei Li
Xuebing Zhang
Yuli Wang
Weiwei Peng

Frontiers in Oncology

doi 10.3389/fonc.2021.783158

2,194 views
2 citations

Review

Published on 12 Jan 2022

Nanomaterial Technology and Triple Negative Breast Cancer

in Pharmacology of Anti-Cancer Drugs

Kai Hou
Zeng Ning
Hongbo Chen
Yiping Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.828810

3,900 views
18 citations

Original Research

Published on 11 Jan 2022

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology

in Pharmacology of Anti-Cancer Drugs

Amanda B. Kagan
Blake S. Moses
Bryan T. Mott
Ganesha Rai
Nicole M. Anders
Michelle A. Rudek
Curt I. Civin

Frontiers in Oncology

doi 10.3389/fonc.2021.790037

2,122 views
6 citations

Review

Published on 10 Jan 2022

Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs

in Pharmacology of Anti-Cancer Drugs

Hai-ni Wen
Chen-yu Wang
Jin-meng Li
Zheng Jiao

Frontiers in Oncology

doi 10.3389/fonc.2021.814699

1,971 views
5 citations

Review

Published on 10 Jan 2022

Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies

in Pharmacology of Anti-Cancer Drugs

Zhengyang Yang
Wei Deng
Xiao Zhang
Yongbo An
Yishan Liu
Hongwei Yao
Zhongtao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.789330

3,390 views
12 citations

Original Research

Published on 10 Jan 2022

DFT Study on the Substituent Effect of Anticancer Picoline-Diazido-Pt(IV) Compounds

in Pharmacology of Anti-Cancer Drugs

Meilin Mu
Hongwei Gao

Frontiers in Oncology

doi 10.3389/fonc.2021.749178

2,106 views
2 citations

Original Research

Published on 10 Jan 2022

Revealing the Role of lncRNA CCDC144NL-AS1 and LINC01614 in Gastric Cancer via Integrative Bioinformatics Analysis and Experimental Validation

in Pharmacology of Anti-Cancer Drugs

Weiwei Sheng
Weihong Zhou
Yundi Cao
Yuejiao Zhong

Frontiers in Oncology

doi 10.3389/fonc.2021.769563

3,207 views
5 citations

Case Report

Published on 07 Jan 2022

Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy

in Pharmacology of Anti-Cancer Drugs

Federica Recine
Alessandro De Vita
Valentina Fausti
Federica Pieri
Alberto Bongiovanni
Eugenia Franchini
Roberto Casadei
Maria Cristina Falasconi
Devil Oboldi
Federica Matteucci

Frontiers in Oncology

doi 10.3389/fonc.2021.740676

5,740 views
21 citations

Review

Published on 06 Jan 2022

Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis

in Pharmacology of Anti-Cancer Drugs

Chuqi Wang
Ming Chu

Frontiers in Oncology

doi 10.3389/fonc.2021.783309

4,014 views
13 citations

Navigation group

Articles

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma

Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia

Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting System

The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis

Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report

Nanomaterial Technology and Triple Negative Breast Cancer

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology

Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs

Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies

DFT Study on the Substituent Effect of Anticancer Picoline-Diazido-Pt(IV) Compounds

Revealing the Role of lncRNA CCDC144NL-AS1 and LINC01614 in Gastric Cancer via Integrative Bioinformatics Analysis and Experimental Validation

Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy

Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis